References
- 1de la Fuente-FernandezRRole of DaTSCAN and clinical diagnosis in Parkinson diseaseNeurology20127869670110.1212/WNL.0b013e318248e52022323748
- 2FelicioACGodeiro-JuniorCMoriyamaTSet alDegenerative parkinsonism in patients with psychogenic parkinsonism: a dopamine transporter imaging studyClin Neurol Neurosurg201011228228510.1016/j.clineuro.2009.12.01020061077
- 3BenaderetteSZanotti FregonaraPApartisEet alPsychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracyMov Disord20062131031710.1002/mds.2072016211590
- 4SeibylJPSingle-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disordersSemin Nucl Med20083827428610.1053/j.semnuclmed.2008.03.00118514083
- 5MortonRJGuyMJClaussRHintonPJMarshallCAClarkeEAComparison of different methods of DatSCAN quantificationNucl Med Commun2005261139114610.1097/00006231-200512000-0001516264363
- 6
- 7FahnSOakesDShoulsonIet alLevodopa and the progression of Parkinson's diseaseN Engl J Med20043512498250810.1056/NEJMoa03344715590952
- 8BajajNHauserRAGrachevIDClinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromesJ Neurol Neurosurg Psychiatry 2013doi:10.1136/jnnp-2012-304436.
- 9SchwingenschuhPRugeDEdwardsMJet alDistinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study Mov Disord20102556056910.1002/mds.2301920131394
- 10UtiumiMAFelícioACBorgesCRet alDopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of Scans Without Evidence of Dopaminergic Deficit (SWEDDs)Arq Neuropsiquiatr20127066767310.1590/S0004-282X201200090000422990721
